NovoCure Limited (NVCR) Operating margin 2017–2026
NovoCure Limited (NVCR) operating margin by fiscal year — reported operating income divided by reported revenue.
-23.5%FY2026 · since FY2017: -139.1% → -23.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -23.5% | +4.7 pp |
| FY2025 | -28.2% | +17.5 pp |
| FY2024 | -45.7% | -29.1 pp |
| FY2023 | -16.6% | -8.4 pp |
| FY2022 | -8.3% | -14.4 pp |
| FY2021 | 6.1% | +6.4 pp |
| FY2020 | -0.3% | +13.3 pp |
| FY2019 | -13.6% | +8.6 pp |
| FY2018 | -22.2% | +116.9 pp |
| FY2017 | -139.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice